| Code | CSB-RA011626MB4HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to reference antibody TQC2938, targeting IL1RL1 (Interleukin 1 Receptor Like 1), also known as ST2. IL1RL1 functions as a receptor for IL-33 and plays a critical role in type 2 immune responses and inflammatory signaling pathways. Upon IL-33 binding, IL1RL1 activates downstream signaling cascades involving NF-κB and MAP kinases, promoting the production of pro-inflammatory cytokines. This receptor is implicated in various pathological conditions including allergic diseases, asthma, cardiovascular disorders, and fibrotic conditions. Both membrane-bound and soluble forms of IL1RL1 exist, with the soluble form acting as a decoy receptor that modulates IL-33 activity.
As a biosimilar to TQC2938, this antibody provides researchers with a reliable tool for investigating IL1RL1 expression, localization, and function in cellular and disease models. It supports studies examining the IL-33/IL1RL1 axis in immune regulation, inflammatory responses, and potential therapeutic interventions. This antibody enables exploration of IL1RL1's role across diverse research areas including immunology, inflammation biology, and translational medicine.
There are currently no reviews for this product.